Ligand validation:4QZE

DCT: 2',3'-DIDEOXYCYTIDINE 5'-TRIPHOSPHATE

DCT is a Ligand Of Interest in 4QZE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4QZE_DCT_A_604	75%	29%	0.149	0.982	1.35	1.48	3	6	1	0	100%	1
4QZG_DCT_A_604	67%	22%	0.172	0.983	1.43	1.81	4	11	0	0	100%	1
4QZF_DCT_A_604	64%	12%	0.171	0.97	2.11	1.97	11	11	0	0	100%	1
4QZH_DCT_A_604	61%	19%	0.193	0.984	1.73	1.75	5	8	0	0	100%	1
4QZI_DCT_A_605	13%	8%	0.286	0.954	2.46	2.2	4	5	0	0	33%	0.3333
4N5S_DCT_A_907	96%	48%	0.077	0.987	0.81	1.2	-	2	0	0	100%	1
3PX6_DCT_D_202	95%	36%	0.085	0.987	0.93	1.57	1	9	2	0	100%	1
4DQP_DCT_D_901	94%	39%	0.091	0.991	0.94	1.43	1	4	0	0	100%	1
4BWJ_DCT_A_1833	94%	6%	0.068	0.965	2.61	2.56	8	7	0	0	100%	1
4QZB_DCT_A_603	92%	30%	0.092	0.985	1.33	1.46	5	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.